A variety of dermatological conditions are linked to endocannabinoid tone and production within the skin. Because CB2 receptors play a key role in immune response, cannabinoid medicines can reduce skin inflammation. Cannabinoid medicines developed by Phytecs may even play a significant role in the treatment of certain skin tumors because of their potent anti-proliferative activity. Endocannabinoids control production of sebum and adjusting endocannabinoid production within the skin could form the basis for acne treatments that are both highly effective and non-irritating.
Because the body’s endocannabinoid system regulates so many aspects of skin function, Phytecs researchers are investigating the use of cannabinoid therapies in maintaining beautiful skin. Endocannabinoids regulate skin inflammation, oil production, and even play a role in unwanted hair growth. Skin care products that target the endocannabinoid system are likely to be a fundamental element of next-generation cosmetic treatments.
It is important for policy makers to understand that cannabis medicine extends far beyond inhaled and oral administration methods. The use of cannabinoids in both dermatological and cosmetic applications is both safe and produces few side effects. Topical cannabinoid treatments show great promise in treating serious conditions such as melanoma.
From prescription medicines to over-the-counter nutraceuticals and cosmetics, Phytecs is developing a broad range of formulations for skin care. Because these products work within the skin’s own natural regulatory system, they produce fewer adverse effects than other skin preparations. Through strategic partnerships, Phytecs can bring these innovations to markets around the globe.
ECS Skin by Artwork by John Karapelou, Text by Phytecs is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License